Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

NCT04563299 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Subject Enrollment

Conditions

Neovascular Age-related Macular Degeneration
Diabetic Macular Edema
Retinal Vein Occlusion

Interventions

DRUG: Dextenza 0.4Mg Ophthalmic Insert
DRUG: Prednisolone Acetate

Sponsor

Retina Vitreous Associates of Florida

Collaborators

[object Object]